Here we present, for the first time we believe, the neuropathological findings in an HSP type 8 (SPG8) case with a confirmed KIAA0196 mutation.
HSP is clinically and genetically a heterogeneous group of disorders with more than 72 loci and 55 genes known to be involved so far (12) . SPG8 has been described in 13 families (2, 5, 8, 10) and presents as a pure spastic paraplegia without associated neurological abnormalities in all families but one (2) . SPG8 is caused by mutations in the strumpellin gene KIAA0196. Eleven different missense mutations (2, 5, 10) and one large deletion in intron 10 -exon 15 of KIAA0196 (10) have been identified so far in patients with SPG8 (www.hgmd.cf.ac.uk). Strumpellin knockdown experiments in human neuroblastoma cells demonstrated reduced axonal outgrowth, and knockdown studies in zebrafish revealed severe contractile cardiac dysfunction, tail curvature, and impaired motility, implying a strumpellin loss-of-function pathogenesis of SPG8 (3).
The major neuropathological finding in pure HSP is axonal degeneration, maximal in the terminal portions of the longest descending and ascending tracts (1) . A case-control study quantifying corticospinal tract axon number showed reduced cross-sectional area and axonal density in the corticospinal tracts with a more pronounced axonal loss in the distal neuraxis in HSP patients. The cross-sectional area and axonal density of the sensory tracts were reduced only in the upper regions of the spinal cord. This is consistent with a "dying back" axonal degeneration (6) .
The proband presented here is a 46-year-old male with a slowly progressing spastic paraplegia. He was healthy until the age of 37, where he had onset of pain in the lower limbs, (Fig. 2) .
The early reports on the neuropathological changes in HSP were published before the genetic background of the HSP subtypes was known. With increasing knowledge of the molecular basis of HSP it is possible to relate the neuropathological findings for the different subtypes of HSP to the function of the proteins encoded by the corresponding genes. Caution 5 is necessary, however, as HSP often does not shorten lifespan, and neuropathological observations may be associated with age or age-associated diseases (7).
We found pronounced atrophy of the spinal cord, with only remnants of nervous tissue between the two enlargements in post mortem tissue from a woman with a confirmed mutation in KIAA0196. To our knowledge such severe atrophy has not previously been reported in HSP. Spinal cord atrophy is commonly found in SPG8 as well as in other types of SPG. SPG6 and SPG8 appear to have particularly severe spinal cord atrophy. A study using magnetic resonance imaging found a significantly higher degree of cord atrophy in SPG6 and 8 compared to SPG3A and 4 (9) . Although a neuropathological study found no correlation between cross-sectional area and axonal loss in HSP of unknown genetic type (6), our findings do indeed indicate a high degree of spinal cord atrophy in SPG8. An autopsy case of HSP with thin corpus callosum had severe degeneration in the lateral and anterior corticospinal tracts, spinocerebellar tracts and posterior column as reported in a case study by Kuru et al. (2005) . This was, however, not an HSP8 case, but a complicated type of HSP that was not subtyped (11) . Another autopsy case compatible with a complicated form of autosomal recessive HSP, but not further subtyped, had severe atrophy of the ventral and lateral corticospinal tracts in the spinal cord (13) .
From the SPG8 case presented here by us it appears that the almost complete atrophy of spinal cord nervous tissue, would be a characteristic neuropathological finding of HSP type 8. 
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